These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15005011)

  • 1. The influence of N-acetyltransferase 2 polymorphism on rheumatoid arthritis activity.
    Pawlik A; Ostanek L; Brzosko I; Brzosko M; Dabrowska-Zamojcin E; Gawronska-Szklarz B
    Clin Exp Rheumatol; 2004; 22(1):99-102. PubMed ID: 15005011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased genotype frequency of N-acetyltransferase 2 slow acetylation in patients with rheumatoid arthritis.
    Pawlik A; Ostanek L; Brzosko I; Gawroska-Szklarz B; Brzosko M; Dabrowska-Zamojcin E
    Clin Pharmacol Ther; 2002 Sep; 72(3):319-25. PubMed ID: 12235453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-alpha -308 promoter polymorphism in patients with rheumatoid arthritis.
    Pawlik A; Florczak M; Ostanek L; Brzosko M; Brzosko I; Szklarz BG
    Scand J Rheumatol; 2005; 34(1):22-6. PubMed ID: 15903021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acetyltransferase 2 (NAT2) polymorphism in patients with atopic asthma.
    Pawlik A; Juzyszyn Z; Gawronska-Szklarz B
    Arch Med Res; 2009 May; 40(4):264-7. PubMed ID: 19608015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects of sulfasalazine in patients with rheumatoid arthritis are associated with diplotype configuration at the N-acetyltransferase 2 gene.
    Tanaka E; Taniguchi A; Urano W; Nakajima H; Matsuda Y; Kitamura Y; Saito M; Yamanaka H; Saito T; Kamatani N
    J Rheumatol; 2002 Dec; 29(12):2492-9. PubMed ID: 12465141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis.
    Huang YS; Chern HD; Su WJ; Wu JC; Lai SL; Yang SY; Chang FY; Lee SD
    Hepatology; 2002 Apr; 35(4):883-9. PubMed ID: 11915035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetyltransferase-2 genotypes among patients with rheumatoid arthritis attending Jordan University Hospital.
    Oqal MK; Mustafa KN; Irshaid YM
    Genet Test Mol Biomarkers; 2012 Sep; 16(9):1007-10. PubMed ID: 22731637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between TGF-β1 (869C/T) polymorphism and biochemical risk factor for prediction of disease progression in rheumatoid arthritis.
    Hussein YM; Mohamed RH; El-Shahawy EE; Alzahrani SS
    Gene; 2014 Feb; 536(2):393-7. PubMed ID: 24315820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The -590 IL-4 promoter polymorphism in patients with rheumatoid arthritis.
    Pawlik A; Wrzesniewska J; Florczak M; Gawronska-Szklarz B; Herczynska M
    Rheumatol Int; 2005 Nov; 26(1):48-51. PubMed ID: 15660235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
    Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
    Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL1beta+3953 exon 5 and IL-2 -330 promoter polymorphisms in patients with rheumatoid arthritis.
    Pawlik A; Kurzawski M; Florczak M; Gawronska Szklarz B; Herczyńska M
    Clin Exp Rheumatol; 2005; 23(2):159-64. PubMed ID: 15895884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis.
    Pawlik A; Kurzawski M; Szklarz BG; Herczynska M; Drozdzik M
    Clin Rheumatol; 2005 Sep; 24(5):480-4. PubMed ID: 15915323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of the N-acetyltransferase (NAT2), smoking and the potential risk of periodontal disease.
    Meisel P; Timm R; Sawaf H; Fanghänel J; Siegmund W; Kocher T
    Arch Toxicol; 2000 Aug; 74(6):343-8. PubMed ID: 11005681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A slow acetylator genotype associated with an increased risk of advanced cervical cancer.
    Costa S; Medeiros R; Vasconcelos A; Pinto D; Lopes C
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):678-82. PubMed ID: 12474054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sE-Selectin expression and A561C polymorphism in relation to rheumatoid arthritis clinical activity.
    Navarro-Hernández RE; Oregón-Romero E; Rangel-Villalobos H; Vázquez-Del Mercado M; Ruiz-Quezada SL; Maldonado-González M; Torres-Vitela R; Muñoz-Valle JF
    J Rheumatol; 2006 Oct; 33(10):1968-72. PubMed ID: 17014013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
    Ranganath VK; Elashoff DA; Khanna D; Park G; Peter JB; Paulus HE;
    J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of FcgammaRIIa polymorphism on rheumatoid arthritis].
    Pawlik A; Ostanek L; Brzosko I; Dabrowska-Zamojcin E; Brzosko M; Florczak M; Gawrońska-Szklarz B
    Pol Arch Med Wewn; 2004 Aug; 112(2):907-10. PubMed ID: 15675264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 promoter polymorphism in patients with rheumatoid arthritis.
    Pawlik A; Wrzesniewska J; Florczak M; Gawronska-Szklarz B; Herczynska M
    Scand J Rheumatol; 2005; 34(2):109-13. PubMed ID: 16095005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype of N-acetyltransferase 2 (NAT2) polymorphism in children with immunoglobulin E-mediated food allergy.
    Gawronska-Szklarz B; Pawlik A; Czaja-Bulsa G; Górnik W; Luszawska-Kutrzeba T; Wrześniewska J
    Clin Pharmacol Ther; 2001 May; 69(5):372-8. PubMed ID: 11372006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.